WAD-28449-02268
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 890 / NV
- Registered
- 2020-12-14
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-14
Registered in v-safe
-
2020-12-14
Dose 1 — Pfizer-BioNTech
- 2020-12-14
- 2020-12-15
- 2020-12-16
- 2020-12-17
- 2020-12-19
- 2020-12-21
- 2020-12-30
-
2021-01-04
Dose 2 — Pfizer-BioNTech
- 2021-01-04
-
2021-01-05
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Mild dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Pregnancy — Feeling: Good · Fatigue or tiredness, NauseaFree text: In early pregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-10
- 2021-04-09
- 2021-07-07
- 2022-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-14 | Pfizer-BioNTech | |
| 2 | 2021-01-04 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Mild dizziness
Systemic reaction (other): In early pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Exposure during pregnancy | ○ | ○ | ○ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release